Shares of Vir Biotechnology Inc. (VIR) are rising over 26% in pre-market today, after the company announced signing of a binding agreement to enter into a collaboration with GlaxoSmithKline plc (GSK) to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.
from RTT - Before the Bell https://ift.tt/39LOAYw
via IFTTT
No comments:
Post a Comment